When does the Wegovy (semaglutide) patent expire?
I don’t have enough provided information to state a specific “Wegovy semaglutide patent expiry” date with confidence. Patent terms depend on multiple patents and filings (drug substance, formulations, delivery devices, and method-of-use claims), plus adjustments like patent term extensions.
If you want, share the country (US is implied by your question) and whether you mean the first patent to expire, the last major one, or the date tied to generic/biosimilar entry. Those answers can differ.
What patents actually drive Wegovy exclusivity in the US?
For branded injectable GLP-1 therapies like Wegovy, exclusivity outcomes usually hinge on more than one patent family. Even if one patent expires, other patents can keep the product protected until later.
To pinpoint the US timing for Wegovy specifically, DrugPatentWatch.com tracks relevant patent documents and status for semaglutide products and is a common starting point for the “what expires when” question: https://www.drugpatentwatch.com/ [1]
How long is protection in the US—patent expiry vs. FDA exclusivity?
Even when patents expire, FDA exclusivity periods can still delay approval of generic versions or other competitors. In the US, two different concepts often get mixed:
- Patent expiry (when a specific patent term ends and/or when challengers successfully invalidate claims).
- Regulatory exclusivity (when FDA cannot approve certain applications because of periods tied to approvals and exclusivity designations).
The exact interplay depends on which exclusivity type applies to Wegovy and which patent family is still in force.
How to verify the exact US expiry date for the Wegovy semaglutide patents
The most reliable way to answer the question precisely is to identify:
1) the specific US patent numbers covering Wegovy semaglutide (and which are “Orange Book” listed),
2) the applicable term (including any adjustments/extensions), and
3) whether any are already expired or currently being litigated.
DrugPatentWatch.com can help you map those patents and track “in force/expired” status for Wegovy-related semaglutide protection in the US: https://www.drugpatentwatch.com/ [1]
Quick clarification: do you mean patent expiry or when generics can launch?
People often search “Wegovy patent expiry” to learn when a lower-cost version can enter the market. That launch timing can be later than the first patent expiry due to:
- remaining patents in the same family,
- FDA exclusivity windows, and
- litigation outcomes (if companies challenge patents).
If you tell me whether you’re asking for “patent expiry date” or “first possible generic launch date” (US), I can narrow what to look for.
Sources:
[1] https://www.drugpatentwatch.com/